LOCAMETZ — NOVARTIS, approved 2025-03-28 (NDA215841).
306 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.